Enveric Biosciences Inc vs Toyota Motor Corp — how do they compare? Enveric Biosciences Inc trades at $1.4 (market cap $5.32M), while Toyota Motor Corp trades at $179.58 (market cap $210.48B). The key difference: Toyota Motor Corp is far larger — about 39563.9× Enveric Biosciences Inc's market cap, and Toyota Motor Corp pays a 3.54% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | TM | |
|---|---|---|
Market Cap | $5.32M | $210.48B |
Sector | Health | Consumer Cyclical |
52-Week High | $17.40 | $248.29 |
52-Week Low | $1.28 | $166.50 |
Enterprise Value | $408.82K | $374.67B |
Dividend Yield | — | 3.54% |
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.38, up 4.55% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported a net loss of $8.77M for 2025, though it beat EPS estimates in all four quarters. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003, including IND-enabling studies and positive preclinical results.
Outlook hinges on clinical progress, with 75% analyst buy ratings supporting potential upside, but high financial losses and negative ROE/ROA pose significant risks. Investors face volatility from regulatory developments and funding needs, making it speculative despite positive sentiment from recent operational updates.
Toyota Motor (TM) trades at $179.34, up 1.77% today, with a neutral technical signal and bullish moving averages. The stock shows strong fundamentals with a P/E of 9.69 and consistent earnings beats, including Q1 2026 EPS of $4.00 versus $3.11 expected. Recent news highlights a $3.6 billion Texas plant expansion to shift Tacoma production from Mexico, signaling growth commitment.
TM presents a value opportunity with attractive valuation ratios and solid profitability, but faces risks from competitive pressures and fluctuating net income margins. Analyst consensus is mixed with 37.5% buy ratings, indicating cautious optimism. The stock's outlook hinges on successful execution of US manufacturing investments and hybrid vehicle demand amid economic uncertainties.
Trailing returns across standard periods
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →